FDA Approved Lab-Grown Blood Vessel Despite Warnings

Dr. Hooman Noorchashm, co-director of the Amy J. Reed Medical Device Safety Collaborative at Northeastern Law, weighs in on the controversy surrounding the FDA’s approval of a bioengineered blood vessel called Symvess, despite questionable study results. “The FDA should not have approved a product that its scientists deemed inferior to existing options,” he tells The New York Times.